Literature DB >> 11474669

New treatments for psoriasis.

R D Granstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474669     DOI: 10.1056/NEJM200107263450410

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells.

Authors:  Jaime García de Tena; Luis Manzano; Juan Carlos Leal; Esther San Antonio; Verónica Sualdea; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2004-03       Impact factor: 8.317

2.  Population pharmacokinetic modeling of subcutaneously administered etanercept in patients with psoriasis.

Authors:  Ivan Nestorov; Ralph Zitnik; Thomas Ludden
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-12       Impact factor: 2.745

3.  Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis.

Authors:  Ivan Nestorov; Ralph Zitnik; Todd DeVries; Arline M Nakanishi; Andrea Wang; Christopher Banfield
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

Review 4.  Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis.

Authors:  Wendy Myers; Mobolaji Opeola; Alice B Gottlieb
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

Review 5.  Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective.

Authors:  David Kane; Oliver FitzGerald
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

6.  Rapid Remission of Psoriasis After Sleeve Gastrectomy.

Authors:  Baris Dogu Yildiz
Journal:  Indian J Surg       Date:  2015-09-28       Impact factor: 0.656

7.  Original inhibition method of excessive synthesis of pro-inflammatory cytokine of tumour necrosis factor α.

Authors:  AleXander Zinchuk; Olga Holubovska; Andrij Shkurba; Roman Hrytsko; Olga Vorozhbyt; Mykhailo Richniak; Borys Herasun
Journal:  Cent Eur J Immunol       Date:  2015-10-15       Impact factor: 2.085

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.